Growth Metrics

Plus Therapeutics (PSTV) Receivables - Net (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Receivables - Net for 13 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 50.0% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, down 50.0% year-over-year, with the annual reading at $300000.0 for FY2025, 50.0% down from the prior year.
  • Receivables - Net for Q4 2025 was $300000.0 at Plus Therapeutics, down from $1.0 million in the prior quarter.
  • The five-year high for Receivables - Net was $1.0 million in Q2 2025, with the low at $300000.0 in Q4 2025.